Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Shunji Nagakawa"'
Publikováno v:
Clinical Drug Investigation. 31:735-743
Background and Objectives: Pitavastatin is a highly effective lipid-lowering drug (approved dose range 1–4 mg/day) with a distinctive metabolic pathway that has a low potential for drug interactions. The efficacy and safety of pitavastatin have bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8aa5a7c8d0b4d81dae18c7ed09b34ee
https://doi.org/10.2165/11592480-000000000-00000
https://doi.org/10.2165/11592480-000000000-00000
Publikováno v:
Clinical Drug Investigation. 2011, Vol. 31 Issue 10, p735-743. 9p.